An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial
International Immunopharmacology (2021) - Comments
pubmed: 34224994  doi: 10.1016/j.intimp.2021.107916  issn: 1567-5769  issn: 1878-1705 

Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, Mohamad Amin Pourhoseingholi, Minoosh Shabani, Shervin Shokouhi, Masoud Mardani, Omid Moradi, Farid Javandoust Gharehbagh, Nasrinsadat Mirtalaee, Halimeh Negahban, Mahdi Amirdosara, Masoud Zangi, Mohammadreza Hajiesmaeili, Muhanna Kazempour, Navid Shafigh